On-Demand Webinar Archives

On-Demand Webinar

SDTM Trial Summary Domain Puzzle: Are These the Right Pieces?

TS can be complex to implement with guidance spread across SDTMIG, FDA Study Data Technical…

CertaraSeptember 10, 2021

On-Demand Webinar

What does the Clinical Pharmacology Plan for a Biologic Look Like?

Monoclonal antibodies are now widely used in the treatment of several diseases, providing effective and…

CertaraAugust 6, 2021

On-Demand Webinar

PBPK Modeling of Tizanidine Systemic Exposure by CYP1A2 Modulation: Impact of DDIs & Smoking

This webinar was presented on June 30, 2021 by David R. Taft, Ph.D. Professor, Pharmaceutics,…

CertaraJuly 26, 2021

On-Demand Webinar

Open-Source Modeling Tools: Fueling the Fire vs. Extinguishing the Debate

The paper “Opening a Debate on Open-Source Modelling Tools: Pouring Fuel on Fire vs. Extinguishing…

CertaraJuly 15, 2021

On-Demand Webinar

Three Pathways have emerged in Innovative Access Agreements

The days of simply determining the market demand for a new drug as a function…

CertaraJune 11, 2021

On-Demand Webinar

Outcomes Based Agreements

The days of simply determining the market demand for a new drug as a function…

CertaraJune 11, 2021

On-Demand Webinar

De-risk your program with evidence-based secondary pharmacology insights

Safety issues account for about a quarter of the attrition in drug projects and can…

CertaraMay 28, 2021

On-Demand Webinar

Stakeholder perspectives: current and potential benefits

Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…

CertaraMay 26, 2021

On-Demand Webinar

Strengths and opportunities for HTAs and market access in Europe through case studies

Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…

CertaraMay 26, 2021

On-Demand Webinar

Similarities and differences between SNDS and other claim databases

Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…

CertaraMay 25, 2021

On-Demand Webinar

SDTM Trial Summary Domain Puzzle: Are These the Right Pieces?

What does the Clinical Pharmacology Plan for a Biologic Look Like?

PBPK Modeling of Tizanidine Systemic Exposure by CYP1A2 Modulation: Impact of DDIs & Smoking

Open-Source Modeling Tools: Fueling the Fire vs. Extinguishing the Debate

Three Pathways have emerged in Innovative Access Agreements

Outcomes Based Agreements

De-risk your program with evidence-based secondary pharmacology insights

Stakeholder perspectives: current and potential benefits

Strengths and opportunities for HTAs and market access in Europe through case studies

Similarities and differences between SNDS and other claim databases

Newsletter sign up

Quick links

Solutions

Contact